BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29577968)

  • 1. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
    Cangemi R; Carnevale R; Nocella C; Calvieri C; Cammisotto V; Novo M; Castellani V; D'Amico A; Zerbinati C; Stefanini L; Violi F;
    Pharmacol Res; 2018 May; 131():66-74. PubMed ID: 29577968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation is associated with myocardial infarction in patients with pneumonia.
    Cangemi R; Casciaro M; Rossi E; Calvieri C; Bucci T; Calabrese CM; Taliani G; Falcone M; Palange P; Bertazzoni G; Farcomeni A; Grieco S; Pignatelli P; Violi F; ;
    J Am Coll Cardiol; 2014 Nov; 64(18):1917-25. PubMed ID: 25444147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
    DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
    Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased thromboxane biosynthesis in essential thrombocythemia.
    Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
    Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired analysis of urinary thromboxane B2 metabolites in humans.
    Catella F; FitzGerald GA
    Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding.
    Pignatelli P; Pastori D; Bartimoccia S; Menichelli D; Vicario T; Nocella C; Carnevale R; Violi F
    Pharmacol Res; 2016 Nov; 113(Pt A):484-489. PubMed ID: 27693274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
    Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
    Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
    Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
    Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary 11-Dehydro-Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study.
    Szczeklik W; Stodółkiewicz E; Rzeszutko M; Tomala M; Chrustowicz A; Żmudka K; Sanak M
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet reactivity in Klinefelter men: something new to consider.
    Di Minno MN; Esposito D; Di Minno A; Accardo G; Lupoli G; Cittadini A; Giugliano D; Pasquali D
    Andrology; 2015 Sep; 3(5):876-81. PubMed ID: 26216452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
    Davì G; Basili S; Vieri M; Cipollone F; Santarone S; Alessandri C; Gazzaniga P; Cordova C; Violi F
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1794-9. PubMed ID: 9412557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Platelets; 2011; 22(3):188-95. PubMed ID: 21231857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients.
    Pignatelli P; Pastori D; Farcomeni A; Nocella C; Bartimoccia S; Vicario T; Bucci T; Carnevale R; Violi F
    Clin Nutr; 2015 Oct; 34(5):899-903. PubMed ID: 25288566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
    Gurbel PA; Bliden KP; Tantry US
    J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.
    Pastori D; Carnevale R; Nocella C; Bartimoccia S; Novo M; Cammisotto V; Piconese S; Santulli M; Vasaturo F; Violi F; Pignatelli P;
    J Am Heart Assoc; 2018 Nov; 7(22):e009509. PubMed ID: 30571484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.
    Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo.
    Landolfi R; Ciabattoni G; Patrignani P; Castellana MA; Pogliani E; Bizzi B; Patrono C
    Blood; 1992 Oct; 80(8):1965-71. PubMed ID: 1327286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.